This new research looks at the effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder.
Read morePsilocybin for Inner Healing Depression
The journey to healing from depression often demands more than just symptom management; it requires a deep, inner transformation that addresses the root of emotional distress.
This inner healing process is crucial for those suffering from depression, as it can lead to more profound and lasting recovery.
Read morePromising Results for Depression Treatment with Microdosing LSD
This development underscores MindBio’s commitment to advancing psychedelic medicine as a viable option for mental health treatment.
Read moreDrumming for Depression?
Rhythmic drumming keeps you centered in the present moment.
This fact – and the evidence for drumming’s mental health benefits – led to the formulation of a type of therapy called Therapeutic Rhythm and Mindfulness (TRM).
Read moreThe Importance of Therapy!
A study published recently in PLOS One suggests that therapy may, in fact, play an important role in psilocybin-assisted therapy for major depressive disorder.
In a study of 24 participants with MDD, those who reported stronger alliance, or “sense of collaboration between patient and client,” with their therapist were more likely to show improvements in their depression scores after two psilocybin dosing sessions.
Stronger ratings of therapeutic alliance during the study’s final preparation session were correlated with improved depression scores for 12 months after the study.
Read moreCan Psychedelics Treat Pessimism?
Are psychedelics an antidote to pessimism?
Research indicates that psychedelic therapy can improve mental health outcomes by addressing the pessimism bias.
Read moreNext-Gen Psilocybin
CYB003 is a next-generation psilocybin designed to provide a faster onset of action and to reduce the duration of effects, ultimately thinning the financial barrier to access of this medicine in a medical setting.
The trial’s interim data demonstrated “rapid, robust, and clinically significant reduction of depression symptoms” three weeks after a single 12mg dose of CYB003.
Read moreDMT and SSRIs
Additionally, 92% experienced remission from depression.
Read morePsilocybin, Cancer and Depression
This pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms.
Read morePsilocybin-based Treatment Combined with Therapy
Ketamine For Depression
This ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read more